TGFB1 and cancer: Along this line, several clinical studies have indicated that cancer progression is associated with loss of TGFβ receptors in types of cancers where TGFβ mutation is rare or in the case of colon cancer, in patient samples without microsatellite instability thereby implying a lack of mutation [57-62].